Enhanced molecular interactions between S100B and WT-p53 proteins in melanoma patient samples were demonstrated to impair WT-p53 function for tumor suppression through restricted cell cycle arrest [29], which leads to increased resistance to chemotherapeutics [11,12,37,38,39]. This evidence concerns the gene TP53 and melanoma.